|
GB9801398D0
(en)
|
1998-01-22 |
1998-03-18 |
Anggard Erik E |
Chemical compounds
|
|
IT1301759B1
(it)
*
|
1998-06-19 |
2000-07-07 |
Nicox Sa |
Sali nitrati di farmaci antiipertensivi
|
|
IT1311923B1
(it)
|
1999-04-13 |
2002-03-20 |
Nicox Sa |
Composti farmaceutici.
|
|
IE20000052A1
(en)
*
|
1999-04-29 |
2000-11-29 |
Russinsky Ltd |
Nitric acid salts of B-blockers
|
|
IT1314184B1
(it)
*
|
1999-08-12 |
2002-12-06 |
Nicox Sa |
Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
|
|
WO2001017528A1
(en)
|
1999-09-08 |
2001-03-15 |
Nitromed, Inc. |
Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
|
|
US7708989B2
(en)
*
|
1999-10-29 |
2010-05-04 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
US7537785B2
(en)
|
1999-10-29 |
2009-05-26 |
Nitromed, Inc. |
Composition for treating vascular diseases characterized by nitric oxide insufficiency
|
|
CA2386954C
(en)
|
1999-10-29 |
2011-12-13 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
US7235237B2
(en)
|
1999-10-29 |
2007-06-26 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
|
EP1246621A4
(en)
*
|
1999-12-23 |
2004-11-24 |
Nitromed Inc |
NITROSED AND NITROSYLATED CYCLOOXYGENASE-2 INHIBITORS, COMPOSITIONS AND METHODS FOR THEIR USE
|
|
AU3838901A
(en)
|
2000-02-16 |
2001-08-27 |
Illumina Inc |
Parallel genotyping of multiple patient samples
|
|
JP2004501143A
(ja)
|
2000-06-22 |
2004-01-15 |
ニトロメド インコーポレーテッド |
ニトロソ化およびニトロシル化タキサン、組成物および使用方法
|
|
EP1337283A4
(en)
*
|
2000-10-27 |
2005-05-18 |
Nitromed Inc |
METHODS OF TREATING VASCULAR DISEASES CHARACTERIZED BY NITROGEN MONOXIDE INSUFFICIENCY
|
|
EP1219306A1
(en)
*
|
2000-12-29 |
2002-07-03 |
Nicox S.A. |
Compositions comprising cyclodextrins and NO- releasing drugs
|
|
CA2446064A1
(en)
|
2001-05-02 |
2002-11-07 |
Nitromed, Inc. |
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
CA2475209A1
(en)
|
2002-02-04 |
2003-08-14 |
Alfama - Investigacao E Desenvolvimento De Produtos Farmaceuticos Lda. |
Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
|
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
WO2003069333A1
(en)
|
2002-02-14 |
2003-08-21 |
Illumina, Inc. |
Automated information processing in randomly ordered arrays
|
|
JP2006501161A
(ja)
*
|
2002-06-11 |
2006-01-12 |
ニトロメッド インク． |
ニトロソ化および／またはニトロシル化シクロオキシゲナーゼ−２選択的阻害剤、組成物ならびに使用方法
|
|
US20060247216A1
(en)
*
|
2002-10-25 |
2006-11-02 |
Haj-Yehia Abdullah I |
Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
|
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
|
AU2003283789A1
(en)
*
|
2002-11-22 |
2004-06-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-blockers having antioxidant and nitric oxide-donor activity
|
|
AU2003286389A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Ace-inhibitors having antioxidant and nitricoxid-donor activity
|
|
US20070207217A1
(en)
*
|
2003-02-03 |
2007-09-06 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO
|
|
US7166638B2
(en)
|
2003-05-27 |
2007-01-23 |
Nicox S.A. |
Statin derivatives
|
|
US7169805B2
(en)
|
2003-05-28 |
2007-01-30 |
Nicox S.A. |
Captopril derivatives
|
|
EP1635816B1
(en)
*
|
2003-06-19 |
2009-03-04 |
NicOx S.A. |
Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
|
|
WO2005018561A2
(en)
*
|
2003-08-20 |
2005-03-03 |
Nitromed, Inc. |
Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
|
|
CA2548129A1
(en)
|
2003-12-02 |
2005-06-16 |
Nicox S.A. |
Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs
|
|
ATE423107T1
(de)
*
|
2003-12-02 |
2009-03-15 |
Nicox Sa |
Nitrooxyderivate von blutdrucksenkenden arzneimitteln
|
|
WO2005068421A1
(en)
*
|
2004-01-05 |
2005-07-28 |
Nicox, S.A. |
Prostaglandin nitrooxyderivatives
|
|
AU2005274763A1
(en)
*
|
2004-07-16 |
2006-02-23 |
Nitromed, Inc. |
Compositions and methods related to heart failure
|
|
AU2005276624B2
(en)
*
|
2004-08-25 |
2011-09-29 |
Actelion Pharmaceuticals Ltd. |
Bicyclononene derivatives as renin inhibitors
|
|
AU2005304770A1
(en)
*
|
2004-11-08 |
2006-05-18 |
Nicox S.A. |
Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders
|
|
AU2006206249A1
(en)
*
|
2005-01-21 |
2006-07-27 |
Nicox S.A. |
Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use
|
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
|
CA2608212A1
(en)
*
|
2005-05-27 |
2006-12-07 |
Actelion Pharmaceuticals Ltd |
Novel piperidine carboxylic acid amide derivatives
|
|
WO2007000641A2
(en)
*
|
2005-06-29 |
2007-01-04 |
Pfizer Inc. |
Prostaglandin derivatives
|
|
CA2626568A1
(en)
*
|
2005-10-18 |
2007-04-26 |
Nicox S.A. |
Renin inhibitors nitroderivatives
|
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
|
JP2009526767A
(ja)
|
2006-02-02 |
2009-07-23 |
アクテリオン ファーマシューティカルズ リミテッド |
新規二級アミン
|
|
EP1984010A4
(en)
*
|
2006-02-17 |
2010-09-08 |
Nitromed Inc |
METHOD FOR USE OF HYDRALAZIN COMPOUNDS AND ISOSORBIDE DINITRATE OR ISOSORBIDE MONONITRATE
|
|
JP2009529033A
(ja)
*
|
2006-03-08 |
2009-08-13 |
アクテリオン ファーマシューティカルズ リミテッド |
新規アミン
|
|
JP2007275193A
(ja)
*
|
2006-04-04 |
2007-10-25 |
Fujifilm Corp |
光プローブおよび光断層画像化装置
|
|
AU2007254283A1
(en)
*
|
2006-05-16 |
2007-11-29 |
Nitromed, Inc. |
Solid dosage formulations of hydralazine compounds
|
|
RU2322972C1
(ru)
*
|
2006-09-12 |
2008-04-27 |
Илья Николаевич Медведев |
Способ профилактики тромбозов у больных артериальной гипертонией с метаболическим синдромом
|
|
TW200831079A
(en)
*
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Angiotensin II receptor antagonists
|
|
FR2921365B1
(fr)
*
|
2007-09-21 |
2012-10-12 |
Servier Lab |
Nouveaux sels d'addition d'inhibiteurs d'enzyme de conversion de l'angiotensine a des acides donneurs de no, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
BRPI0912388A2
(pt)
|
2008-05-05 |
2017-09-26 |
Merck Frosst Canada Ltd |
composto, forma cristalina, processo para preparar compostos, composição farmacêutica, e, uso de um composto, e, método para o tratamento ou profilaxia de doenças
|
|
WO2010116270A1
(en)
|
2009-04-10 |
2010-10-14 |
Pfizer Inc. |
Ep2/4 agonists
|
|
WO2011160974A2
(en)
|
2010-06-21 |
2011-12-29 |
Nicox S.A. |
Statin derivatives
|
|
PT2699242T
(pt)
|
2011-04-19 |
2018-01-22 |
Alfama Inc |
Moléculas de libertação de monóxido de carbono e utilizações das mesmas
|
|
EP2734235B1
(en)
|
2011-07-21 |
2017-03-22 |
Alfama, Inc. |
Ruthenium carbon monoxide releasing molecules and uses thereof
|
|
US9844599B2
(en)
|
2013-01-21 |
2017-12-19 |
Apparao Satyam |
Nitric oxide releasing produgs of therapeutic agents
|
|
WO2018087092A1
(en)
|
2016-11-08 |
2018-05-17 |
Bausch & Lomb Incorporated |
Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma
|
|
FI3993876T3
(fi)
|
2019-07-01 |
2024-11-28 |
Tonix Pharma Ltd |
Cd154-vasta-aineita ja niiden käyttötarkoituksia
|
|
AU2022205313A1
(en)
|
2021-01-06 |
2023-07-20 |
Tonix Pharma Limited |
Methods of inducing immune tolerance with modified anti-cd154 antibodies
|
|
WO2025248134A1
(en)
|
2024-05-31 |
2025-12-04 |
Tonix Pharma Limited |
Treatment methods comprising administration of modified cd154 antibodies
|